Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anne Hellkamp"'
Autor:
Dana Leifer, Gregg C. Fonarow, Anne Hellkamp, David Baker, Brian L. Hoh, Shyam Prabhakaran, Mark Schoeberl, Robert Suter, Chad Washington, Scott Williams, Ying Xian, Lee H. Schwamm
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 15 (2021)
Background Previous studies of patients with nontraumatic subarachnoid hemorrhage (SAH) suggest better outcomes at hospitals with higher case and procedural volumes, but the shape of the volume‐outcome curve has not been defined. We sought to estab
Externí odkaz:
https://doaj.org/article/d060def33a994dc58e79b48ac0eb77bf
Autor:
Marc D. Samsky, Anne Hellkamp, William R. Hiatt, F. Gerry R. Fowkes, Iris Baumgartner, Jeffrey S. Berger, Brian G. Katona, Kenneth W. Mahaffey, Lars Norgren, Juuso I. Blomster, Frank W. Rockhold, Adam D. DeVore, Manesh R. Patel, W. Schuyler Jones
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 12 (2021)
Background Peripheral artery disease (PAD) and heart failure (HF) are each independently associated with poor outcomes. Risk factors associated with new‐onset HF in patients with primary PAD are unknown. Furthermore, how the presence of HF is assoc
Externí odkaz:
https://doaj.org/article/8443e47a670245ccb2104c004277aebe
Autor:
William T. Wang, Anne Hellkamp, Jacob A. Doll, Laine Thomas, Ann Marie Navar, Gregg C. Fonarow, Howard M. Julien, Eric D. Peterson, Tracy Y. Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 3 (2018)
BackgroundThe 2013 American College of Cardiology/American Heart Association cholesterol guidelines recommend high‐intensity statins for patients after myocardial infarction (MI) rather than treating to a low‐density lipoprotein cholesterol goal,
Externí odkaz:
https://doaj.org/article/a39fa29882854876933f046b9dbcb36b
Autor:
Adam D Devore, Anne Hellkamp, Laine E Thomas, Nancy M Albert, Javed Butler, J Herbert H Patterson, John Spertus, Fredonia Williams, Xian Shen, Adrian F Hernandez, Gregg C Fonarow
Publikováno v:
Circulation. 144
Background: Among patients with heart failure with reduced ejection fraction (HFrEF), improvements in left ventricular EF (LVEF) are associated with better outcomes in select populations. How changes in LVEF are associated with outcomes in routine cl
Autor:
Sean Chen, Anne Hellkamp, Brooke Alhanti, Chiara Melloni, Jonathan P Piccini, Michel G Khouri, Christopher Granger, Sean Pokorney
Publikováno v:
Circulation. 144
Introduction: Use of oral anticoagulation (OAC) in patients with atrial fibrillation (AF) and cancer is challenging due to increased thrombotic and bleeding risks, and data on prescription patterns are lacking. Hypothesis: Underutilization of OAC amo
Autor:
Brittany Chapman, Anne Hellkamp, Laine Thomas, Nancy Albert, Javed Butler, J. Herbert Patterson, Adrian Hernandez, Fredonia Williams, Xian Shen, John Spertus, Gregg Fonarow, Adam Devore
Publikováno v:
Journal of Cardiac Failure. 28:S33
Autor:
Sean Chen, Anne Hellkamp, Brooke Alhanti, Chiara Melloni, Jonathan P. Piccini, Michel Georges Khouri, Christopher B. Granger, Sean Pokorney
Publikováno v:
Journal of the American College of Cardiology. 79:113
Autor:
Eric E Smith, Phyo Myint, Anne Hellkamp, Gregg Fonarow, Matthew Reeves, Lee Schwamm, Phillip Schulte, Ying Xian, Robert Suter, Deepak Bhatt, Jeffrey Saver, Eric Peterson
Publikováno v:
Stroke. 47
Introduction: Trials have demonstrated that antithrombotic medications can prevent ischemic stroke, but it is unclear if prior therapy can also improve outcomes from those still having an acute ischemic stroke. Hypothesis: Antithombotics are the main
Autor:
Anne Hellkamp, Laine Thomas, Luis Gruberg, James L. de Lemos, Tracy Wang, Amr Mohsen, Jonathan Enriquez, Benjamin Scirica, Anthony Hilliard
Publikováno v:
Journal of the American College of Cardiology. 65(10)
Autor:
William E Kraus, Mark P Donahue, Svati H Shah, David J Whellan, Anne Hellkamp, Christopher M O’Connor, G. M Felker
Publikováno v:
Circulation. 127
Blood-borne small metabolic intermediates have been associated with disease severity and major adverse coronary events (MACE), including mortality alone, in a cardiovascular disease population. Specifically, short chain dicarboxylacylcarnitines (SCDC